The pharmaceutical sector saw broad-based gains in early trade on November 29, 2024, with Cipla and Sun Pharma leading the charge. Here’s a detailed look at the top pharma stocks as of 10:34 AM:
Stock Highlights:
Cipla:
Cipla surged 2.46%, gaining ₹36.75 to trade at ₹1,529.50, emerging as one of the top gainers in the pharma pack.
Sun Pharma:
Sun Pharma advanced 2.41%, climbing ₹41.75 to trade at ₹1,776.00, supported by strong buying interest.
Divi’s Laboratories:
Divi’s Labs recorded a gain of 2.26%, rising ₹134.65 to trade at ₹6,086.45.
Torrent Pharma:
Torrent Pharma added 2.16%, gaining ₹69.05 to trade at ₹3,272.00, maintaining its upward momentum.
Alkem Laboratories:
Alkem saw a rise of 1.80%, adding ₹98.10 to trade at ₹5,555.25.
Lupin:
Lupin gained 1.66%, up ₹33.10 to trade at ₹2,031.50.
Zydus Lifesciences:
Zydus Life climbed 1.54%, adding ₹14.65 to trade at ₹963.35.
Dr. Reddy’s Laboratories:
Dr. Reddy’s was up 1.19%, gaining ₹14.15 to trade at ₹1,206.10.
Ipca Laboratories:
Ipca Labs advanced 1.04%, up ₹15.75 to trade at ₹1,528.75.
Abbott India:
Abbott India gained 0.97%, adding ₹265.90 to trade at ₹27,644.20.
Aurobindo Pharma:
Auro Pharma edged higher by 0.85%, gaining ₹10.55 to trade at ₹1,248.95.
Biocon:
Biocon rose 0.80%, up ₹2.90 to trade at ₹366.85.
Glenmark Pharmaceuticals:
Glenmark added 0.75%, gaining ₹11.15 to trade at ₹1,506.30.
Mankind Pharma:
Mankind Pharma slipped marginally by 0.07%, trading down ₹1.85 at ₹2,558.55.
GlaxoSmithKline Pharma:
Glaxo fell 0.14%, losing ₹3.40 to trade at ₹2,410.20.
The pharmaceutical sector displayed resilience in morning trade, led by strong gains in Cipla and Sun Pharma. Positive investor sentiment continues to drive the sector forward.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Please consult a qualified financial advisor before making any investment decisions.
